ID   CRYM_HUMAN              Reviewed;         314 AA.
AC   Q14894; D5MNX0; Q5HYB7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Ketimine reductase mu-crystallin;
DE            EC=1.5.1.25;
DE   AltName: Full=NADP-regulated thyroid-hormone-binding protein;
GN   Name=CRYM; Synonyms=THBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=9285773;
RA   Segovia L., Horwitz J., Gasser R., Wistow G.;
RT   "Two roles for mu-crystallin: a lens structural protein in diurnal
RT   marsupials and a possible enzyme in mammalian retinas.";
RL   Mol. Vis. 3:9-9(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9328354; DOI=10.1210/mend.11.11.9915;
RA   Vie M.-P., Evrard C., Osty J., Breton-Gilet A., Blanchet P., Pomerance M.,
RA   Rouget P., Francon J., Blondeau J.-P.;
RT   "Purification, molecular cloning, and functional expression of the human
RT   nicotinamide-adenine dinucleotide phosphate-regulated thyroid hormone-
RT   binding protein.";
RL   Mol. Endocrinol. 11:1728-1736(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Sperbeck S.J., Segovia L., Wistow G.J.;
RT   "Human and mouse Mu-crystallin.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10493829; DOI=10.1006/geno.1999.5927;
RA   Loftus B.J., Kim U.-J., Sneddon V.P., Kalush F., Brandon R., Fuhrmann J.,
RA   Mason T., Crosby M.L., Barnstead M., Cronin L., Mays A.D., Cao Y., Xu R.X.,
RA   Kang H.-L., Mitchell S., Eichler E.E., Harris P.C., Venter J.C.,
RA   Adams M.D.;
RT   "Genome duplications and other features in 12 Mb of DNA sequence from human
RT   chromosome 16p and 16q.";
RL   Genomics 60:295-308(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterine endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 4-18; 57-83; 177-186; 243-277 AND 292-314, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 37-314.
RC   TISSUE=Retina;
RX   PubMed=1384048; DOI=10.1073/pnas.89.19.9292;
RA   Kim R.Y., Gasser R., Wistow G.J.;
RT   "Mu-crystallin is a mammalian homologue of Agrobacterium ornithine
RT   cyclodeaminase and is expressed in human retina.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:9292-9296(1992).
RN   [12]
RP   INVOLVEMENT IN DFNA40, AND VARIANTS DFNA40 THR-314 AND
RP   TYR-ASN-LYS-GLY-THR-314 EXT.
RX   PubMed=12471561; DOI=10.1086/345398;
RA   Abe S., Katagiri T., Saito-Hisaminato A., Usami S., Inoue Y., Tsunoda T.,
RA   Nakamura Y.;
RT   "Identification of CRYM as a candidate responsible for nonsyndromic
RT   deafness, through cDNA microarray analysis of human cochlear and vestibular
RT   tissues.";
RL   Am. J. Hum. Genet. 72:73-82(2003).
RN   [13]
RP   FUNCTION AS A KETIMINE REDUCTASE, CATALYTIC ACTIVITY, KINETIC PARAMETERS,
RP   AND PH DEPENDENCE.
RX   PubMed=21332720; DOI=10.1111/j.1471-4159.2011.07220.x;
RA   Hallen A., Cooper A.J., Jamie J.F., Haynes P.A., Willows R.D.;
RT   "Mammalian forebrain ketimine reductase identified as mu-crystallin;
RT   potential regulation by thyroid hormones.";
RL   J. Neurochem. 118:379-387(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2-313 IN COMPLEX WITH NADPH,
RP   SUBUNIT, AND NADP-BINDING SITES.
RX   PubMed=17242435; DOI=10.1110/ps.062556907;
RA   Cheng Z., Sun L., He J., Gong W.;
RT   "Crystal structure of human micro-crystallin complexed with NADPH.";
RL   Protein Sci. 16:329-335(2007).
CC   -!- FUNCTION: Specifically catalyzes the reduction of imine bonds in brain
CC       substrates that may include cystathionine ketimine (CysK) and
CC       lanthionine ketimine (LK). Binds thyroid hormone which is a strong
CC       reversible inhibitor. Presumably involved in the regulation of the free
CC       intracellular concentration of triiodothyronine and access to its
CC       nuclear receptors. {ECO:0000269|PubMed:21332720}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + thiomorpholine-3-carboxylate = 3,4-
CC         dehydrothiomorpholine-3-carboxylate + 2 H(+) + NADH;
CC         Xref=Rhea:RHEA:12504, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:58047, ChEBI:CHEBI:58517; EC=1.5.1.25;
CC         Evidence={ECO:0000269|PubMed:21332720};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + thiomorpholine-3-carboxylate = 3,4-
CC         dehydrothiomorpholine-3-carboxylate + 2 H(+) + NADPH;
CC         Xref=Rhea:RHEA:12500, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58047, ChEBI:CHEBI:58349, ChEBI:CHEBI:58517; EC=1.5.1.25;
CC         Evidence={ECO:0000269|PubMed:21332720};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=47 uM for 3,4-dehydro-thiomorpholine-3-carboxylate (at pH 5.0 and
CC         37 degrees Celsius) {ECO:0000269|PubMed:21332720};
CC         KM=3.6 uM for NADH (at pH 5.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:21332720};
CC         Vmax=9.6 umol/min/mg enzyme with 3,4-dehydro-thiomorpholine-3-
CC         carboxylate as substrate (at pH 5.0 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:21332720};
CC       pH dependence:
CC         Optimum pH is 4.5. {ECO:0000269|PubMed:21332720};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17242435}.
CC   -!- INTERACTION:
CC       Q14894; Q96CV9: OPTN; NbExp=3; IntAct=EBI-7107048, EBI-748974;
CC       Q14894; P54274: TERF1; NbExp=2; IntAct=EBI-7107048, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed in neural tissue, muscle and kidney.
CC   -!- DISEASE: Deafness, autosomal dominant, 40 (DFNA40) [MIM:616357]: A form
CC       of non-syndromic sensorineural hearing loss. Sensorineural deafness
CC       results from damage to the neural receptors of the inner ear, the nerve
CC       pathways to the brain, or the area of the brain that receives sound
CC       information. {ECO:0000269|PubMed:12471561}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ornithine cyclodeaminase/mu-crystallin
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L02950; AAC16914.1; -; mRNA.
DR   EMBL; U85772; AAB81564.1; -; mRNA.
DR   EMBL; AF039397; AAB94938.1; -; Genomic_DNA.
DR   EMBL; AF039392; AAB94938.1; JOINED; Genomic_DNA.
DR   EMBL; AF039393; AAB94938.1; JOINED; Genomic_DNA.
DR   EMBL; AF039394; AAB94938.1; JOINED; Genomic_DNA.
DR   EMBL; AF039395; AAB94938.1; JOINED; Genomic_DNA.
DR   EMBL; AF039396; AAB94938.1; JOINED; Genomic_DNA.
DR   EMBL; AK290852; BAF83541.1; -; mRNA.
DR   EMBL; BX648477; CAI46030.1; -; mRNA.
DR   EMBL; AF001550; AAB67600.1; -; Genomic_DNA.
DR   EMBL; CH471228; EAW66863.1; -; Genomic_DNA.
DR   EMBL; BC018061; AAH18061.1; -; mRNA.
DR   CCDS; CCDS10597.1; -.
DR   PIR; B46290; B46290.
DR   RefSeq; NP_001879.1; NM_001888.4.
DR   PDB; 2I99; X-ray; 2.60 A; A/B=2-313.
DR   PDBsum; 2I99; -.
DR   SMR; Q14894; -.
DR   BioGRID; 107815; 7.
DR   IntAct; Q14894; 7.
DR   MINT; Q14894; -.
DR   STRING; 9606.ENSP00000219599; -.
DR   DrugBank; DB05235; NRP409.
DR   iPTMnet; Q14894; -.
DR   PhosphoSitePlus; Q14894; -.
DR   BioMuta; CRYM; -.
DR   DMDM; 2498259; -.
DR   EPD; Q14894; -.
DR   jPOST; Q14894; -.
DR   MassIVE; Q14894; -.
DR   PaxDb; Q14894; -.
DR   PeptideAtlas; Q14894; -.
DR   PRIDE; Q14894; -.
DR   ProteomicsDB; 60215; -.
DR   Antibodypedia; 12355; 315 antibodies.
DR   DNASU; 1428; -.
DR   Ensembl; ENST00000219599; ENSP00000219599; ENSG00000103316.
DR   Ensembl; ENST00000543948; ENSP00000440227; ENSG00000103316.
DR   Ensembl; ENST00000572914; ENSP00000461904; ENSG00000103316.
DR   GeneID; 1428; -.
DR   KEGG; hsa:1428; -.
DR   UCSC; uc002dim.4; human.
DR   CTD; 1428; -.
DR   DisGeNET; 1428; -.
DR   GeneCards; CRYM; -.
DR   HGNC; HGNC:2418; CRYM.
DR   HPA; ENSG00000103316; Tissue enhanced (blood, brain, heart muscle).
DR   MalaCards; CRYM; -.
DR   MIM; 123740; gene.
DR   MIM; 616357; phenotype.
DR   neXtProt; NX_Q14894; -.
DR   OpenTargets; ENSG00000103316; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   PharmGKB; PA26924; -.
DR   VEuPathDB; HostDB:ENSG00000103316.10; -.
DR   eggNOG; KOG3007; Eukaryota.
DR   GeneTree; ENSGT00390000000237; -.
DR   InParanoid; Q14894; -.
DR   OMA; AVKAFTY; -.
DR   OrthoDB; 1345495at2759; -.
DR   PhylomeDB; Q14894; -.
DR   TreeFam; TF105309; -.
DR   BioCyc; MetaCyc:ENSG00000103316-MONOMER; -.
DR   PathwayCommons; Q14894; -.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   BioGRID-ORCS; 1428; 6 hits in 988 CRISPR screens.
DR   ChiTaRS; CRYM; human.
DR   EvolutionaryTrace; Q14894; -.
DR   GeneWiki; CRYM; -.
DR   GenomeRNAi; 1428; -.
DR   Pharos; Q14894; Tbio.
DR   PRO; PR:Q14894; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q14894; protein.
DR   Bgee; ENSG00000103316; Expressed in cortical plate and 211 other tissues.
DR   ExpressionAtlas; Q14894; baseline and differential.
DR   Genevisible; Q14894; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0042562; F:hormone binding; IBA:GO_Central.
DR   GO; GO:0050661; F:NADP binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0047127; F:thiomorpholine-carboxylate dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0070324; F:thyroid hormone binding; IDA:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IMP:UniProtKB.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0042403; P:thyroid hormone metabolic process; IBA:GO_Central.
DR   GO; GO:0070327; P:thyroid hormone transport; IMP:UniProtKB.
DR   Gene3D; 3.30.1780.10; -; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR003462; ODC_Mu_crystall.
DR   InterPro; IPR023401; ODC_N.
DR   PANTHER; PTHR13812; PTHR13812; 1.
DR   Pfam; PF02423; OCD_Mu_crystall; 1.
DR   PIRSF; PIRSF001439; CryM; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Deafness; Direct protein sequencing;
KW   Disease variant; NAD; NADP; Non-syndromic deafness; Oxidoreductase;
KW   Reference proteome.
FT   CHAIN           1..314
FT                   /note="Ketimine reductase mu-crystallin"
FT                   /id="PRO_0000200678"
FT   NP_BIND         143..148
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17242435"
FT   BINDING         168
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17242435"
FT   BINDING         169
FT                   /note="NADP"
FT                   /evidence="ECO:0000269|PubMed:17242435"
FT   VARIANT         314
FT                   /note="K -> KYNKGT (in DFNA40)"
FT                   /evidence="ECO:0000269|PubMed:12471561"
FT                   /id="VAR_073780"
FT   VARIANT         314
FT                   /note="K -> T (in DFNA40; dbSNP:rs104894512)"
FT                   /evidence="ECO:0000269|PubMed:12471561"
FT                   /id="VAR_073781"
FT   STRAND          6..8
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           10..16
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           20..23
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           24..35
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           37..40
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          48..52
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           53..55
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          57..66
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   TURN            67..70
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          71..80
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          84..87
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          89..99
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   TURN            101..103
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          106..111
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           113..131
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          138..142
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           146..158
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          162..167
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           171..180
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          181..183
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           191..195
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          199..203
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           214..216
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          222..225
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           238..243
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          244..249
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           251..257
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           259..262
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   TURN            263..265
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           272..277
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   STRAND          288..291
FT                   /evidence="ECO:0007744|PDB:2I99"
FT   HELIX           296..310
FT                   /evidence="ECO:0007744|PDB:2I99"
SQ   SEQUENCE   314 AA;  33776 MW;  A49D316B41CE6648 CRC64;
     MSRVPAFLSA AEVEEHLRSS SLLIPPLETA LANFSSGPEG GVMQPVRTVV PVTKHRGYLG
     VMPAYSAAED ALTTKLVTFY EDRGITSVVP SHQATVLLFE PSNGTLLAVM DGNVITAKRT
     AAVSAIATKF LKPPSSEVLC ILGAGVQAYS HYEIFTEQFS FKEVRIWNRT KENAEKFADT
     VQGEVRVCSS VQEAVAGADV IITVTLATEP ILFGEWVKPG AHINAVGASR PDWRELDDEL
     MKEAVLYVDS QEAALKESGD VLLSGAEIFA ELGEVIKGVK PAHCEKTTVF KSLGMAVEDT
     VAAKLIYDSW SSGK
//
